Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Global initiative for chronic obstructive lung disease 2020.(Available at:) (Accessed May 30, 2020)
- Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD.J Chronic Obstr Pulm Dis. 2017; 14: 72-79
- Exacerbations in the pre- and post-COPD diagnosis periods.Pragmat Obs Res. 2013; 4: 1-6
- UK National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations.Respiration. 2011; 82: 320-327
- A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation.Chest. 2009; 136: 376-380
- Hospitalizations and deaths associated with EVALI.N Engl J Med. 2020; 382: 1589-1598
- Infectious etiology of acute exacerbations of chronic bronchitis.Chest. 2000; 117: 380s-385s
- Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease.Ann Am Thorac Soc. 2014; 11: 303-309
- Acute exacerbations in chronic obstructive pulmonary disease: should we use antibiotics and if so, which ones?.Curr Opin Infect Dis. 2019; 32: 143-151
- Acute exacerbations of chronic bronchitis: diagnosis and therapy; first, determine the cause of the worsening symptoms.J Respir Dis. 2003; 24: 257-263
- Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.Chest. 2006; 129: 317-324
- Procalcitonin level-guided treatment reduced antibiotic use in exacerbations of COPD.ACP J Club. 2007; 146: 57
- Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.Chest. 2007; 131: 9-19
- Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.Ann Intern Med. 1987; 106: 196-204
- Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.Chest. 2000; 117: 1638-1645
- International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.Lancet. 2007; 370: 741-750
- Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey.BMJ. 2003; 327: 653-654
- Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD.Cochrane Database Syst Rev. 2016; (CD011826)
- Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2003; (CD003900)
- Systematic literature review of systemic corticosteroid use for asthma management.Am J Respir Crit Care Med. 2020; 201: 276-293
- Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.Am J Respir Crit Care Med. 2012; 186: 48-55
- Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.Eur Respir J. 2014; 44: 789-791
- Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.J Clin Microbiol. 2014; 52: 2813-2823
- Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.Eur Respir J. 2017; 49: 1600791
- Antibiotics for exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2018; (CD010257)
- Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.Infect Dis Clin North Am. 2004; 18 (ix): 861-882
- Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary.Can Respir J. 2003; 10: 248-258
- Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group.Eur Respir J. 2001; 17: 928-933
- Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.Eur Respir J. 2012; 40: 17-27
- Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis.Thorax. 2006; 61: 337-342
- Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure.COPD. 2010; 7: 337-344
- Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.Antimicrob Agents Chemother. 2005; 49: 153-160
- Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2010; 181: 150-157
- Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.Lancet Respir Med. 2017; 5: 492-499
- Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem.J Med Microbiol. 2019; 68: 1-10
- Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014; (CD001288)
- Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease.N Engl J Med. 1999; 340: 1941-1947
- Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.JAMA. 2013; 309: 2223-2231
- Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.JAMA. 2010; 303: 2035-2042
- Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids.Chest. 2013; 143: 82-90
- Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.BMC Pulm Med. 2014; 14: 103
- Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study.Eur Respir J. 2009; 34: 1072-1078
- Pseudomonas infection in chronic obstructive pulmonary disease.Future Microbiol. 2012; 7: 1129-1132
- Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.Int J Chron Obstruct Pulmon Dis. 2015; 10: 2581-2591
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.Lancet. 2015; 385: 1729-1737
- Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial.BMJ. 2010; 341: c5462
- One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration.Thorax. 2000; 55: 550-554
- Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial.Int J Chron Obstruct Pulmon Dis. 2016; 11: 1983-1990
- Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients.Ann Intensive Care. 2014; 4: 32
- Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?.Intensive Care Med. 2001; 27: 59-67
- Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.Lancet. 2001; 358: 2020-2025
- Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.Eur Respir J. 2017; 50: 1602426
Article info
Identification
Copyright
© 2020 Elsevier Inc. All rights reserved.
